Oh, I'm sorry, it's Médecins Sans Frontières, Doctors Without Borders.
So in order for Apotex to then move forward to be in a position, legally, to sell it to MSF, they needed to be able to go to the brand name companies in Canada that hold the patents on those three drugs and say to them, “We would like you to voluntarily give us a licence to supply x quantity of this drug to this particular country”. They then are required to negotiate for 30 days. If they cannot agree on the terms of a voluntary licence, then Apotex could apply to the Commissioner of Patents for a compulsory licence, and the commissioner, then, would order them to pay the royalty according to the formula in the current law.
But that 30-day window is really part of the problem, because you have to start that 30-day clock ticking if you want to run out the 30 days so that you're in a position to get a compulsory licence. That clock does not start ticking until you tell the brand-name company, “This is the specific country, and this is the quantity of the drug”. So if you can't get a country to come forward ahead of time, you're stuck—